483 Legacy Pharmaceuticals Switzerland Jul 2017

483 Legacy Pharmaceuticals Switzerland Jul 2017

Michael Charles FDA$119.00 - Available Now

FDA investigators audited the Legacy Pharmaceuticals Switzerland - Birsfelden, Switzerland facility and issued inspectional observations (via FDA 483) on 21 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jul 2017
  • Location: Birsfelden, Switzerland
  • FEI: 3007457560
Add To Cart